Article ; Online: Frequency and determinants of serum calcium monitoring during eldecalcitol therapy in patients with osteoporosis.
Journal of bone and mineral metabolism
2023 Volume 41, Issue 6, Page(s) 890–900
Abstract: Introduction: Eldecalcitol (ELD) is an active vitamin D: Materials and methods: This was a descriptive cohort study using a Japanese electronic medical records database. We identified osteoporosis patients who initiated treatment with ELD or other ... ...
Abstract | Introduction: Eldecalcitol (ELD) is an active vitamin D Materials and methods: This was a descriptive cohort study using a Japanese electronic medical records database. We identified osteoporosis patients who initiated treatment with ELD or other AVDs (alfacalcidol and calcitriol) between April 1, 2011 and September 10, 2021. The index date for cohort entry was the first prescription date of ELD or other AVDs. The frequency of serum calcium monitoring was evaluated every 6 months. Determinants of serum calcium monitoring were identified using multivariable logistic regression models. We also calculated the incidence of hypercalcemia and the frequency of serum calcium monitoring within 6 months before hypercalcemia. Results: We identified 12,671 ELD users and 7867 other AVD users. Within 6 months after cohort entry, 45.9% of ELD users and 58.7% of other AVD users underwent serum calcium monitoring. Female sex, no use of systemic corticosteroids, moderate-to-good renal function, treatment in smaller hospitals, and treatment in orthopedic surgery departments were associated with a lower likelihood of receiving serum calcium monitoring during ELD therapy. The incidence of hypercalcemia among ELD users was 6.36 per 100 person-years, with 20.6% of cases not receiving serum calcium monitoring before hypercalcemia. Conclusion: Our findings suggest that serum calcium monitoring is not given adequate attention during ELD therapy in routine clinical practice. |
---|---|
MeSH term(s) | Humans ; Female ; Calcium ; Hypercalcemia/drug therapy ; Hypercalcemia/chemically induced ; Cohort Studies ; Bone Density ; Vitamin D ; Osteoporosis/drug therapy ; Osteoporosis/chemically induced |
Chemical Substances | eldecalcitol (I2JP8UE90H) ; Calcium (SY7Q814VUP) ; Vitamin D (1406-16-2) |
Language | English |
Publishing date | 2023-10-28 |
Publishing country | Japan |
Document type | Journal Article |
ZDB-ID | 1295123-7 |
ISSN | 1435-5604 ; 0914-8779 |
ISSN (online) | 1435-5604 |
ISSN | 0914-8779 |
DOI | 10.1007/s00774-023-01470-7 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4894: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.